UPLOAD Filing
IGC Pharma, Inc.
Date: July 23, 2025 · CIK: 0001326205 · Accession: 0000000000-25-007762
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288785
Letter
Re: IGC Pharma, Inc. Registration Statement on Form S-3 Filed July 18, 2025 File No. 333-288785 Dear Ram Mukunda:
July 23, 2025
Ram Mukunda President and Chief Executive Officer IGC Pharma, Inc. 10224 Falls Road Potomac, Maryland 20854
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: John A. Corrado, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 23, 2025 Ram Mukunda President and Chief Executive Officer IGC Pharma, Inc. 10224 Falls Road Potomac, Maryland 20854 Re: IGC Pharma, Inc. Registration Statement on Form S-3 Filed July 18, 2025 File No. 333-288785 Dear Ram Mukunda: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John A. Corrado, Esq. </TEXT> </DOCUMENT>